ES2061581T3 - Un procedimiento para preparar un compuesto cefem. - Google Patents

Un procedimiento para preparar un compuesto cefem.

Info

Publication number
ES2061581T3
ES2061581T3 ES88114722T ES88114722T ES2061581T3 ES 2061581 T3 ES2061581 T3 ES 2061581T3 ES 88114722 T ES88114722 T ES 88114722T ES 88114722 T ES88114722 T ES 88114722T ES 2061581 T3 ES2061581 T3 ES 2061581T3
Authority
ES
Spain
Prior art keywords
protected
alkil
amino
carboxi
theta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88114722T
Other languages
English (en)
Inventor
Kazuo Sakane
Kohji Kawabata
Kenzi Miyai
Yoshiko Inamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721568A external-priority patent/GB8721568D0/en
Priority claimed from GB888815361A external-priority patent/GB8815361D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2061581T3 publication Critical patent/ES2061581T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

UN COMPONENTE DEFEM DE LA FORMULA: EN DONDE R1 ES AMINO O UN AMINO PROTEGIDO, R2 ES ALKIL BAJO QUE DEBE TENER UNO O MAS SUSTITUYENTES CONVENIENTES, R3 ES COO(THETA), CARBOXI O UN CARBOXI PROTEGIDO, R4 ES HIDROXI (BAJO ALKIL O HIDROXI (BAJO) ALKIL PROTEGIDO , R5 ES AMINO O UN AMINO PROTEGIDO, R6 ES HIDROGENO O ALKIL BAJO, X(THETA) ES UN ANION Y N ES 0 O 1, CON PREVISTO QUE: (I) CUANDO R3 ES COO(THETA), ENTONCES N ES 0 Y (II) CUANDO R3 ES CORBOXI O UN CARBOXI PROTEGIDO, ENTONCES N ES 1. Y SALES ACEPTABLES FARMACEUTICAMENTE DE ELLO, PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LES COMPRENDAN COMO INFGREDIENTES ACTIVOS EN MEZCLA CON PORTADORES ACEPTABLES FARMACEUTICAMENTE.
ES88114722T 1987-09-14 1988-09-09 Un procedimiento para preparar un compuesto cefem. Expired - Lifetime ES2061581T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878721568A GB8721568D0 (en) 1987-09-14 1987-09-14 Cephem compounds
GB888815361A GB8815361D0 (en) 1988-06-28 1988-06-28 New cephem compound & process for preparation thereof

Publications (1)

Publication Number Publication Date
ES2061581T3 true ES2061581T3 (es) 1994-12-16

Family

ID=26292732

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88114722T Expired - Lifetime ES2061581T3 (es) 1987-09-14 1988-09-09 Un procedimiento para preparar un compuesto cefem.

Country Status (22)

Country Link
US (1) US4952578A (es)
EP (1) EP0307804B1 (es)
JP (1) JPH01151589A (es)
KR (1) KR0133560B1 (es)
CN (1) CN1024669C (es)
AU (1) AU617358B2 (es)
CA (1) CA1338842C (es)
DE (1) DE3885688T2 (es)
DK (1) DK509988A (es)
ES (1) ES2061581T3 (es)
FI (1) FI92322C (es)
HK (1) HK18396A (es)
HU (1) HU211830A9 (es)
IE (1) IE63094B1 (es)
IL (1) IL87731A (es)
NO (1) NO171853C (es)
NZ (1) NZ226143A (es)
OA (1) OA09014A (es)
PH (1) PH24719A (es)
PT (1) PT88481B (es)
RU (1) RU1787158C (es)
UA (1) UA41865C2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194432A (en) * 1985-11-22 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
US5162520A (en) * 1986-09-22 1992-11-10 Fujisawa Pharmaceutical Co., Ltd. Intermediates for cephem compounds
US5663163A (en) * 1987-09-07 1997-09-02 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
GB8905301D0 (en) * 1989-03-08 1989-04-19 Fujisawa Pharmaceutical Co New cephem compound and a process for preparation thereof
EP0517041A1 (en) * 1991-06-07 1992-12-09 Fujisawa Pharmaceutical Co., Ltd. New Cephem Compounds
WO2002090364A1 (en) * 2001-05-01 2002-11-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
KR100463920B1 (ko) * 2002-10-18 2004-12-30 제일약품주식회사 신규 세프디토렌 피복실 메지틸렌 설폰산염 및 그 제조방법
JP4448821B2 (ja) * 2002-10-30 2010-04-14 アステラス製薬株式会社 セフェム化合物
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
ES2340928T3 (es) * 2003-09-18 2010-06-11 Astellas Pharma Inc. Compuestos de cefem.
CN1321109C (zh) * 2003-11-07 2007-06-13 天津药物研究院 一种头孢烯类鎓盐化合物及其制备方法和以该化合物合成硫酸头孢吡唑的方法
CN101747348B (zh) * 2008-12-11 2013-02-06 石药集团中奇制药技术（石家庄）有限公司 一种硫酸头孢噻利晶型及其制备方法
CN101781318B (zh) * 2010-02-26 2013-07-31 烟台宝华生物技术有限公司 头孢母核衍生化合物、由其制备的头孢烯类鎓盐化合物及采用其制备硫酸头孢吡唑的方法
CN101830913B (zh) * 2010-04-09 2012-10-31 烟台宝华生物技术有限公司 头孢母核衍生化合物、由其制备的头孢烯类鎓盐化合物及采用其制备硫酸头孢吡唑的方法
CN101993450B (zh) * 2010-11-03 2011-11-30 湖南欧亚生物有限公司 一种硫酸头孢噻利的制备方法
CN102336771A (zh) * 2011-07-11 2012-02-01 珠海联邦制药股份有限公司 一种硫酸头孢噻利中间体的制备方法
JP6151257B2 (ja) 2011-09-09 2017-06-21 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 肺内感染症の治療方法
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CN102875572B (zh) * 2012-10-26 2014-07-30 四川科伦药物研究有限公司 一种硫酸头孢噻利中间体的精制方法
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
UA121298C2 (uk) 2013-03-15 2020-05-12 Мерк Шарп І Доум Корп. Антибіотична композиція на основі цефтолозану і тазобактаму
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
GB2037281B (en) * 1978-11-15 1983-01-19 Glaxo Group Ltd 7( -(2-amino-4-thiozolyl)-2-hydroximino-acetanuds)-cephalosporins
EP0062321B1 (en) * 1981-04-03 1989-03-01 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
JPS584789A (ja) * 1981-04-03 1983-01-11 Fujisawa Pharmaceut Co Ltd 新規セフエム化合物およびその製造法
US4401668A (en) * 1981-10-02 1983-08-30 Eli Lilly And Company Pyrazinium substituted cephalosporins
CA1299564C (en) * 1985-09-03 1992-04-28 Akihiro Shimabayashi Cephalosporin derivative
DE3539901A1 (de) * 1985-11-11 1987-05-14 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
CN86107947A (zh) * 1985-11-22 1987-05-27 藤沢药品工业株式会社 新的头孢烯化合物及其制备方法

Also Published As

Publication number Publication date
JPH01151589A (ja) 1989-06-14
NO884058L (no) 1989-03-15
AU617358B2 (en) 1991-11-28
AU2227188A (en) 1989-03-16
EP0307804A3 (en) 1989-11-08
FI884193A (fi) 1989-03-15
JPH0576950B2 (es) 1993-10-25
IE882692L (en) 1989-03-14
KR890005124A (ko) 1989-05-11
FI884193A0 (fi) 1988-09-13
NO171853B (no) 1993-02-01
HK18396A (en) 1996-02-09
US4952578A (en) 1990-08-28
EP0307804B1 (en) 1993-11-18
DE3885688D1 (de) 1993-12-23
PH24719A (en) 1990-10-01
PT88481B (pt) 1992-11-30
DK509988A (da) 1989-03-15
IE63094B1 (en) 1995-03-22
UA41865C2 (uk) 2001-10-15
NO884058D0 (no) 1988-09-13
CA1338842C (en) 1997-01-14
CN1024669C (zh) 1994-05-25
NO171853C (no) 1993-05-12
FI92322B (fi) 1994-07-15
RU1787158C (ru) 1993-01-07
EP0307804A2 (en) 1989-03-22
HU211830A9 (en) 1995-12-28
IL87731A0 (en) 1989-02-28
KR0133560B1 (ko) 1998-04-23
NZ226143A (en) 1990-11-27
IL87731A (en) 1993-05-13
DE3885688T2 (de) 1994-04-07
CN1032540A (zh) 1989-04-26
PT88481A (pt) 1988-10-01
FI92322C (fi) 1994-10-25
OA09014A (fr) 1991-03-31
DK509988D0 (da) 1988-09-13

Similar Documents

Publication Publication Date Title
ES2061581T3 (es) Un procedimiento para preparar un compuesto cefem.
MX173630B (es) Derivados de aminoacido, procedimiento para su preparacion y su preparacion y medicamento que los contiene
ATE128132T1 (de) N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran oder dihydrobenzodioxin)- carboxamid-derivate.
ES2082805T3 (es) Derivados de tiazol, procedimientos para su produccion y composiciones farmaceuticas que comprenden los mismos.
OA09039A (fr) Acides 3-alcenyl-1-azabicyclo(3.2.0)hep-2-ene-2carboxyliques
ES8402559A1 (es) Un procedimiento para preparar nuevos compuestos peptidicos.
NZ226125A (en) Substituted n(1-alkyl-3-hydroxy-4-piperidinyl) benzamides and pharmaceutical compositions
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
HUT54988A (en) Process for producing substituted n-(quinolin-2-ylmethoxy)-benzylsulfonylureas and pharmaceutical compositions comprising such compounds
ES8608502A1 (es) Procedimiento para la obtencion de benzofuranonas
ATE67406T1 (de) Nicorandil enthaltende zubereitung zum einspritzen.
AU1906788A (en) Substituted N-(3-hydroxy-4-piperidinyl)benzamides
ES470296A1 (es) Mejoras introducidas en un procedimiento para la preparacionde fluormetal-aminoacidos
AU530678B2 (en) Phosphono-hydroxy-acetic acid
ES2037758T3 (es) Un metodo de uso de un derivado quinolincarboxilico y su procedimiento de preparacion.
ES2054186T3 (es) Composicion antihepatopatica.
ES2053652T3 (es) N-(alquilideno sustituido)-1,2,3,4,-tetrahidro-9-acridinaminas, un procedimiento para su preparacion y su uso como medicamentos.
DK351982A (da) Fremgangsmaade til fremstilling af aminoglycosidderivater
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
MY106235A (en) New 2 - carbonyl substituted n, n'' -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.
YU119491A (sh) Novi protivirusni tetrahidroimidazo [1,4] benzodiazepin-2-(ti)oni i postupak njihovog dobijanja
NO933237L (no) Absorbat av en hjelpestoffblanding og et ikke-fast virksomt stoff for fremstilling av legemiddelpreparater
ES2062135T3 (es) Derivados del acido tienilacetico, procedimiento para su obtencion, su empleo, asi como medicamentos que contienen este y su obtencion.
ES440208A1 (es) Procedimiento para la fabricacion de derivados de piperazi- na.
ES2018404A6 (es) Procedimiento para preparar nuevas 2-metoxicarbonil sustituido-n, n'-di-(trimetoxibenzoil)-piperazinas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 307804

Country of ref document: ES